Ramucirumab for Gastric Cancer

被引：0
|
作者：
Satoh, Taroh [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISY-9-3
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study
    Longo, Federico
    Jorge, Monica
    Yaya, Ricardo
    Fernandez Montes, Ana
    Martinez Lago, Nieves
    Brozos, Elena
    Aparicio, Jorge
    Quintero, Guillermo
    Ceballos, Eduardo
    Buxo, Elvira
    Maria Lopez, Ana
    Luz Pellon, Maria
    Molina, Raquel
    Diaz-Paniagua, Laura
    Cerda, Paula
    Lopez Leiva, Pedro
    Martin Carnicero, Alfonso
    Cousillas, Antia
    Paris, Lorena
    Garcia-Paredes, Beatriz
    Romero, Carlos
    Ortega, Maria
    Molero, Alberto
    de la Torre, Sergio
    Jen, Min-Hua
    Diaz-Cerezo, Silvia
    FUTURE ONCOLOGY, 2021, 17 (14) : 1777 - 1791
  • [32] Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
    Natsume, Makoto
    Shimura, Takaya
    Iwasaki, Hiroyasu
    Okuda, Yusuke
    Kitagawa, Mika
    Okamoto, Yasuyuki
    Hayashi, Kazuki
    Kataoka, Hiromi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (06) : 1037 - 1046
  • [33] Bronchobiliary fistula after ramucirumab treatment for advanced gastric cancer: A case report
    Hong-Beum Kim
    Yong Sub Na
    Hee-Jeong Lee
    Sang-Gon Park
    World Journal of Clinical Cases, 2019, 7 (19) : 3039 - 3046
  • [34] Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxel
    Roviello, Giandomenico
    Corona, Silvia P.
    Multari, Andrea G.
    Petrioli, Roberto
    Rosellini, Pietro
    Aieta, Michele
    ANTI-CANCER DRUGS, 2019, 30 (07) : 745 - 748
  • [35] A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan
    Yucherng Chen
    Taeko Katayose
    Soshi Nagaoka
    Yongzhe Piao
    Kensei Yamaguchi
    Hiroya Asou
    Gastric Cancer, 2021, 24 : 1320 - 1329
  • [36] RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer
    Sorokin, Maxim
    Poddubskaya, Elena
    Baranova, Madina
    Glusker, Alex
    Kogoniya, Lali
    Markarova, Ekaterina
    Allina, Daria
    Suntsova, Maria
    Tkachev, Victor
    Garazha, Andrew
    Sekacheva, Marina
    Buzdin, Anton
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2020, 6 (02):
  • [37] Ramucirumab for metastatic gastric or gastroesophageal junction cancer: results and implications of the REGARD trial
    Liguigli, Wanda
    Tomasello, Gianluca
    Toppo, Laura
    Ratti, Margherita
    Passalacqua, Rodolfo
    FUTURE ONCOLOGY, 2014, 10 (09) : 1549 - 1557
  • [38] A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan
    Chen, Yucherng
    Katayose, Taeko
    Nagaoka, Soshi
    Piao, Yongzhe
    Yamaguchi, Kensei
    Asou, Hiroya
    GASTRIC CANCER, 2021, 24 (06) : 1320 - 1329
  • [39] Trifluridine/tipiracil with and without ramucirumab for advanced gastric cancer: a comparative observational study
    Narita, Yukiya
    Ogata, Takatsugu
    Ishizuka, Yasunobu
    Sakakida, Tomoki
    Wakabayashi, Munehiro
    Kodama, Hiroyuki
    Honda, Kazunori
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Kadowaki, Shigenori
    Ando, Masashi
    Tajika, Masahiro
    Muro, Kei
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
    Makoto Natsume
    Takaya Shimura
    Hiroyasu Iwasaki
    Yusuke Okuda
    Mika Kitagawa
    Yasuyuki Okamoto
    Kazuki Hayashi
    Hiromi Kataoka
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 1037 - 1046
12345